133 related articles for article (PubMed ID: 37944712)
1. TGF-β induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids.
Fernandes S; Oliver-De La Cruz J; Morazzo S; Niro F; Cassani M; Ďuríková H; Caravella A; Fiore P; Azzato G; De Marco G; Lauria A; Izzi V; Bosáková V; Fric J; Filipensky P; Forte G
Matrix Biol; 2024 Jan; 125():12-30. PubMed ID: 37944712
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
3. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
4. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
6. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer.
Cichon MA; Radisky DC
Cell Adh Migr; 2014; 8(6):588-94. PubMed ID: 25482625
[TBL] [Abstract][Full Text] [Related]
8. c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer.
Amatangelo MD; Goodyear S; Varma D; Stearns ME
Carcinogenesis; 2012 Oct; 33(10):1965-75. PubMed ID: 22791812
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
11. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells.
Ratz L; Laible M; Kacprzyk LA; Wittig-Blaich SM; Tolstov Y; Duensing S; Altevogt P; Klauck SM; Sültmann H
Oncotarget; 2017 Apr; 8(15):25115-25130. PubMed ID: 28445989
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-β in Physiological and Pathological Conditions.
Tsuda T
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227601
[TBL] [Abstract][Full Text] [Related]
13. An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition.
Hoshiba T
Exp Cell Res; 2018 Sep; 370(2):571-578. PubMed ID: 30016638
[TBL] [Abstract][Full Text] [Related]
14. Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway.
Polimeni M; Gulino GR; Gazzano E; Kopecka J; Marucco A; Fenoglio I; Cesano F; Campagnolo L; Magrini A; Pietroiusti A; Ghigo D; Aldieri E
Part Fibre Toxicol; 2016 Jun; 13(1):27. PubMed ID: 27251132
[TBL] [Abstract][Full Text] [Related]
15. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
16. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury.
Lu H; Chen B; Hong W; Liang Y; Bai Y
FEBS J; 2016 Oct; 283(20):3771-3790. PubMed ID: 27579669
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway.
Kou B; Liu W; Zhao W; Duan P; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q
Oncol Rep; 2017 Dec; 38(6):3592-3598. PubMed ID: 29039572
[TBL] [Abstract][Full Text] [Related]
20. FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.
Karmakar D; Lahiri P; Bedi M; Ghosh A; Ghosh A; Barui A; Varshney SK; Lahiri B; Sengupta S
J Cell Biochem; 2023 Jun; 124(6):849-860. PubMed ID: 37158093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
